Cinnarizine is a piperazine derivative used for the symptomatic treatment of nausea and vertigo and other vestibular disorders and for the prevention and treatment of motion sickness. Cinnarizine prevents calcium-dependent contraction of arterial smooth muscle. It has some H1-receptor antagonistic action.
Cinnarizine is indicated in the control of vestibular symptoms of both peripheral and central origin, the prophylaxis and control of motion sickness, the long-term treatment of peripheral arterial diseases.
Dosage & Administration:
15 mg to 30 mg three times daily.
Other Brands From Same Therapeutic Class